Whereas neutralizing surface-exposed APOL1 with specific APOL1-targeting proteins or drugs appears to reduce the disease [12], totally inactivating APOL1 is expected to increase the patient’s sensitivity to pathogen infection. This evidence concerns the gene APOL1 and infection.